SEARCH
— IC芯片 | 连接器 | 传感器 | 被动器件 —
The ADAS1000-2BCPZ is a five-channel ECG analog front-end designed as a secondary companion device for the ADAS1000 family. It operates in gang mode to expand channel counts beyond five electrodes. The component provides digitized biopotential signals via SPI with 19-bit resolution at 2 kHz data rates. Power consumption reaches 27 mW in high-performance mode with all channels active. It supports AC/DC lead-off detection and includes a calibration DAC input for synchronized testing with primary devices.
Verify package configuration upon receipt; the BCPZ suffix indicates a 56-lead LFCSP variant. Confirm that the design utilizes a primary ADAS1000 controller, as this device lacks standalone interface capabilities. Ensure IOVDD levels match the host processor logic voltage range between 1.65 V and 3.6 V.
Select the ADAS1000-2BCPZ only when expanding an existing ADAS1000-based architecture to increase electrode count. This model excludes respiration measurement and internal pace detection features found in the primary ADAS1000 variant. Use the BCZ suffix if a 64-lead LQFP package is required instead of the LFCSP form factor.
This component belongs to the Analog Devices ADAS1000 series of biopotential analog front-ends. Unlike the standard ADAS1000 which functions as a master, the ADAS1000-2 is a subset device intended strictly for slave/gang operations. It shares the same core ADC and amplifier architecture but omits specific control peripherals to optimize cost and power for multi-device configurations.
Direct functional replacement requires another ADAS1000-2 variant (e.g., ADAS1000-2BCZ) matching the package type. Standalone ADAS1000 units cannot replace this part in a gang configuration without significant hardware redesign.